Cassian Yee study shows progress in using patients' own tumor-fighting cells to knock back late-stage skin cancer
March 5, 2012
| By Dean Forbes
A small, early-phase clinical trial, led by Dr. Cassian Yee of the Hutchinson Center's Clinical Research Division, to test the effectiveness of treating patients with advanced melanoma using billions of clones of their own tumor-fighting cells combined with a specific type of chemotherapy has shown that the approach has promise. One patient of the 11 experienced a long-term, complete remission that has lasted more than three years, and in four others with progressive disease, the melanoma temporarily stopped growing. The results of the study appear in the March 5 early edition of the Proceedings of the National Academy of Sciences.